Advent Access ^Company

Advent Access is a medical technology startup in end stage renal disease management. Founded based on Stanford Biodesign principles and as a spin-off from A*STAR, Advent Access’ mission is to pioneer innovations to significantly reduce dialysis cost and restore quality of life for kidney failure patients in Asia and across the world. Advent Access’ first product is the av-Guardian™ - a device that improves vascular access reliability, reduces cannulation pain and in the long run, preserves the health of an arteriovenous fistula. The av-Guardian™ forms a key component of Advent Access’ dialysis-machine agnostic platform to empower patients to perform hemodialysis independently, safely and more affordably.